Tianjin Chase Sun Pharmaceutical Co Ltd Net Asset Quality Index
Tianjin Chase Sun Pharmaceutical Co Ltd net asset quality index. Tianjin Chase Sun Pharmaceutical Co Ltd (300026) has a Net Asset Quality Index of 84.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥10.37 Billion minus total liabilities of CN¥1.65 Billion yields net assets of CN¥8.72 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Tianjin Chase Sun Pharmaceutical Co Ltd (300026) shareholders funds for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Tianjin Chase Sun Pharmaceutical Co Ltd (2006–2024)
Net asset quality index of Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024. This chart shows how Tianjin Chase Sun Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 19 annual periods from 2006 to 2024. As of March 2026, the index stands at 84.1%, representing net assets of CN¥8.72 Billion against total assets of CN¥10.37 Billion CNY. Check 300026 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Tianjin Chase Sun Pharmaceutical Co Ltd Net Asset Quality Index by Year (2006–2024)
Tianjin Chase Sun Pharmaceutical Co Ltd net asset quality index by year from 2006 to 2024. The table below presents the year-by-year Net Asset Quality Index for Tianjin Chase Sun Pharmaceutical Co Ltd from 2006 to 2024, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Tianjin Chase Sun Pharmaceutical Co Ltd market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 78.8% | CN¥8.80 Billion | CN¥11.17 Billion | CN¥2.37 Billion | ▲ +3.9 pp |
| 2023 | 74.9% | CN¥8.87 Billion | CN¥11.84 Billion | CN¥2.97 Billion | ▲ +7.9 pp |
| 2022 | 67.0% | CN¥8.46 Billion | CN¥12.63 Billion | CN¥4.17 Billion | ▼ -1.5 pp |
| 2021 | 68.5% | CN¥7.95 Billion | CN¥11.61 Billion | CN¥3.65 Billion | ▼ -4.1 pp |
| 2020 | 72.6% | CN¥7.39 Billion | CN¥10.18 Billion | CN¥2.79 Billion | ▼ -11.3 pp |
| 2019 | 83.9% | CN¥7.07 Billion | CN¥8.43 Billion | CN¥1.36 Billion | ▼ -4.0 pp |
| 2018 | 87.9% | CN¥6.58 Billion | CN¥7.48 Billion | CN¥907.61 Million | ▲ +0.3 pp |
| 2017 | 87.6% | CN¥6.51 Billion | CN¥7.43 Billion | CN¥919.62 Million | ▲ +4.7 pp |
| 2016 | 82.9% | CN¥6.04 Billion | CN¥7.28 Billion | CN¥1.24 Billion | ▲ +1.2 pp |
| 2015 | 81.7% | CN¥5.29 Billion | CN¥6.47 Billion | CN¥1.18 Billion | ▲ +4.2 pp |
| 2014 | 77.5% | CN¥2.36 Billion | CN¥3.04 Billion | CN¥684.85 Million | ▲ +0.8 pp |
| 2013 | 76.7% | CN¥1.70 Billion | CN¥2.22 Billion | CN¥516.40 Million | ▼ -0.2 pp |
| 2012 | 77.0% | CN¥1.39 Billion | CN¥1.80 Billion | CN¥415.19 Million | ▲ +2.4 pp |
| 2011 | 74.6% | CN¥1.05 Billion | CN¥1.41 Billion | CN¥357.47 Million | ▼ -11.2 pp |
| 2010 | 85.8% | CN¥1.10 Billion | CN¥1.28 Billion | CN¥182.14 Million | ▼ -1.5 pp |
| 2009 | 87.3% | CN¥926.88 Million | CN¥1.06 Billion | CN¥134.90 Million | ▲ +29.5 pp |
| 2008 | 57.8% | CN¥125.51 Million | CN¥217.14 Million | CN¥91.63 Million | ▲ +22.8 pp |
| 2007 | 35.0% | CN¥61.24 Million | CN¥175.03 Million | CN¥113.79 Million | ▲ +14.8 pp |
| 2006 | 20.1% | CN¥21.28 Million | CN¥105.62 Million | CN¥84.34 Million | — |